Table 1 Clinical data
Variable | Children (8 to 13 years) (n = 55) | Adolescents (14 to 17 years) (n = 41) | Significance level |
|---|---|---|---|
Sex (male) | 43.6% (n = 24) | 58.5% (n = 24) | Â |
Age (mean/SD) | 10.8/1.7 | 15.9/1.80 | Â |
% vital capacity (mean/SD) | 92.5%/11.9% (n = 47) | 97.2%/13.1% (n = 34) | p = 0.082 |
% FEV1 (mean/SD) | 93.6%/15.2% (n = 47) | 90.7%/20.3% (n = 34) | p = 0.618 |
% MEF25 (mean/SD) | 68.4%/41.7% (n = 47) | 58.9%/37.5% (n = 34) | p = 0.273 |
Bacterial colonization of the lung | 63.6% (n = 35) | 73.2% (n = 30) | p = 0.009 |
Pneumothorax | 1.8% (n = 1) | 0% (n = 0) | p = 0.392 |
Allergic bronchopulmonary aspergillosis (ABPA) | 3.6% (n = 2) | 12.2% (n = 5) | p = 0.229 |
Pancreatic insufficiency | 80.0% (n = 44) | 78.1% (n = 32) | p = 0.782 |
Hepatobiliary complications | 23.6% (n = 13) | 26.8% (n = 11) | p = 0.840 |
Distal intestinal obstruction | 7.3% (n = 4) | 0.0% (n = 0) | p = 0.082 |
Diabetes mellitus | 0.0% (n = 0) | 7.3% (n = 3) | p = 0.041 |
Nasal polyp | 10.9% (n = 6) | 17.1% (n = 7) | p = 0.366 |
Isolation obligation for patient | 1.8% (n = 1) | 9.8% (n = 4) | p = 0.081 |